Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

June 30, 2009

Conditions
HIV Infections
Interventions
DRUG

KP-1461

Oral dosage, 1600 mg bid for 124 days

Trial Locations (31)

10018

AIDS Community Research Initiative of America, New York

10029

Mount Sinai Medical Center, New York

12208

Albany Medical College, Albany

19107

Thomas Jefferson University, Division of Infectious Disease, Philadelphia

20009

Dupont Circle Physician's Group, Washington D.C.

Whitman-Walker Clinic, Washington D.C.

21201

Institute of Human Virology, University of Maryland, Baltimore

22003

CARE-ID, Annandale

27710

Duke University Medical Center, Durham

30308

AIDS Research Consortium of Atlanta, Atlanta

32803

Orlando Immunology Center, Orlando

32960

Treasure Coast Infectious Disease Consultants, Vero Beach

33169

Wohlfeiler, Piperato and Associates, LLC, North Miami Beach

33311

Comprehensive Care Center -- HIV Clinical Research, Fort Lauderdale

45267

University of Cincinnati Medical Center, Cincinnati

60657

Northstar Medical Center, Chicago

64106

Dybedal Center for Clinical Research, Kansas City University of Medicine and Biosciences, Kansas City

67214

University of Kansas School of Medicine - PriVia, The Research Centers of Via Christi, Wichita

72207

Health for Life Clinic, Little Rock

75204

Charlton Methodist Hospital, Dallas

77030

University of Texas Health Science Center, Houston

87505

Southwest CARE Center, Santa Fe

90036

Light Source Medical/U. of Southern California, Los Angeles

90813

Living Hope Clinical Foundation, Long Beach

92103

UCSD Antiviral Research Center, San Diego

94115

Quest Clinical Research, San Francisco

95817

ACTU at CARES/UC Davis, Sacramento

98104

University of Washington AIDS Clinical Trials Unit, Seattle

02215

Community Research Initiative of New England, Boston

07102

St. Michael's Medical Center, Newark

00909

Clinical Research Puerto Rico, Inc., San Juan

Sponsors
All Listed Sponsors
lead

Koronis Pharmaceuticals.

INDUSTRY